Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Insulin Resistance 5 Hyperglycemia 3 Polycystic Ovary Syndrome 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Oligomenorrhea 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Intracranial Aneurysm 1 Hypoglycemia 1 Hyperphagia 1 Hyperinsulinism 1 Hyperandrogenism 1 Hirsutism 1 Diabetes Mellitus, Type 1 1 Congenital Abnormalities 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Parenteral Nutrition 9 soybean oil, phospholipid emulsion 4 fish oil triglycerides 3 alanylglutamine 1 SMOFlipid 1 Radiotherapy 1 Parenteral Nutrition, Total 1 Parenteral Nutrition, Home 1 Parenteral Nutrition Solutions 1 Nutrition Assessment 1 Insulin Glargine 1 Insulin 1 Injections 1 Glucose 1 Enteral Nutrition 1 Emulsions 1 Dietary Supplements 1 DNA, Ribosomal 1 Clinical Trials as Topic 1 ClinOleic 1 Cisplatin 1 Cetuximab 1 Amino Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperphagia × Insulin × Clear all

NCT02216799 2016-02-25

GLUCOSE-in-PN

King Faisal Specialist Hospital & Research Center

Phase 4 Completed

Hyperglycemia, Hyperphagia, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡